The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians

Sjögren's syndrome (SS) and Type 1 Diabetes (T1D) are chronic, progressive autoimmune diseases that affect exocrine glands or ?-cells in the islets of Langerhans in the pancreas, respectively. Typical features of both diseases include production of antibodies against self-antigens and T and B c...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2013
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26418
Acceso en línea:
https://doi.org/10.1016/j.clim.2013.05.010
https://repository.urosario.edu.co/handle/10336/26418
Palabra clave:
Chemokine receptor CCR5
DNA
Cell migration
Cell surface
Colombia
DNA polymorphism
Frameshift mutation
Gene deletion
Gene frequency
Genetic association
Genotype
Human
Insulin dependent diabetes mellitus
Letter
Leukocyte
Priority journal
Sjoegren syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
Colombia
Diabetes Mellitus Type 1
Genetic Predisposition to Disease
Humans
Polymorphism Genetic
Receptors CCR5
Sjogren's Syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
Rights
License
Restringido (Acceso a grupos específicos)
id EDOCUR2_6c66e19b23ceb8d66c98ee6cd573868f
oai_identifier_str oai:repository.urosario.edu.co:10336/26418
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 0cd49d13-8737-44a2-a443-b213bf55b4d12e153dda-dae9-49fa-b6b1-167de30398f76eadc8ba-2c67-4c47-8c36-e03c3608a1acd0700cba-aa90-454a-a287-34625d7e7952194747786001deaa8bc-795f-4973-8456-d0f36a56f0b52020-08-06T16:21:39Z2020-08-06T16:21:39Z2013-08-01Sjögren's syndrome (SS) and Type 1 Diabetes (T1D) are chronic, progressive autoimmune diseases that affect exocrine glands or ?-cells in the islets of Langerhans in the pancreas, respectively. Typical features of both diseases include production of antibodies against self-antigens and T and B cell infiltrates in organ-specific tissues [12] . Migration of pro-inflammatory memory T cells and monocytes into chronically inflamed tissues is driven by Th1-related chemokines and their receptors. This includes CCR5, a seven-transmembrane domain G protein-coupled receptor (GPCR) involved in intracellular signaling [3] . In Sjögren's syndrome, mRNA and receptor expression of CCR5 are significantly upregulated in inflammatory Th1 cells, parotid gland excretory ducts and conjunctival epithelium of SS-affected individuals indicating that it has a significant role in the progression and severity of pSS disease [45] . In Type 1 Diabetes, recruitment of activated CCR5-expressing T cells to the pancreas or kidney can promote renal disease and impairment of insulin production [6] .application/pdfhttps://doi.org/10.1016/j.clim.2013.05.010ISSN: 1521-7035Clinical ImmunologyEISSN: 1521-6616https://repository.urosario.edu.co/handle/10336/26418engElsevier208No. 2206Clinical ImmunologyVol. 148Clinical Immunology, ISSN:1521-7035 ; EISSN:1521-6616, Vol.148, No.2 (August, 2013); pp.206-208https://www.sciencedirect.com/science/article/abs/pii/S1521661613001307?via%3DihubRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURChemokine receptor CCR5DNACell migrationCell surfaceColombiaDNA polymorphismFrameshift mutationGene deletionGene frequencyGenetic associationGenotypeHumanInsulin dependent diabetes mellitusLetterLeukocytePriority journalSjoegren syndromeCCR5 delta 32Rs333Sjögren's syndromeType 1 DiabetesColombiaDiabetes Mellitus Type 1Genetic Predisposition to DiseaseHumansPolymorphism GeneticReceptors CCR5Sjogren's SyndromeCCR5 delta 32Rs333Sjögren's syndromeType 1 DiabetesThe CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in ColombiansEl polimorfismo CCR5 delta 32 (rs333) no está asociado con el síndrome de Sjögren o la diabetes tipo 1 en colombianosarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Maier-Moore, Jacen S.Cañas, Carlos A.Tobón, GabrielArango, AlvaroAnaya, Juan-ManuelScofield, R. Hal10336/26418oai:repository.urosario.edu.co:10336/264182021-08-05 17:35:50.43https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
dc.title.TranslatedTitle.spa.fl_str_mv El polimorfismo CCR5 delta 32 (rs333) no está asociado con el síndrome de Sjögren o la diabetes tipo 1 en colombianos
title The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
spellingShingle The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
Chemokine receptor CCR5
DNA
Cell migration
Cell surface
Colombia
DNA polymorphism
Frameshift mutation
Gene deletion
Gene frequency
Genetic association
Genotype
Human
Insulin dependent diabetes mellitus
Letter
Leukocyte
Priority journal
Sjoegren syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
Colombia
Diabetes Mellitus Type 1
Genetic Predisposition to Disease
Humans
Polymorphism Genetic
Receptors CCR5
Sjogren's Syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
title_short The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
title_full The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
title_fullStr The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
title_full_unstemmed The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
title_sort The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians
dc.subject.keyword.spa.fl_str_mv Chemokine receptor CCR5
DNA
Cell migration
Cell surface
Colombia
DNA polymorphism
Frameshift mutation
Gene deletion
Gene frequency
Genetic association
Genotype
Human
Insulin dependent diabetes mellitus
Letter
Leukocyte
Priority journal
Sjoegren syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
Colombia
Diabetes Mellitus Type 1
Genetic Predisposition to Disease
Humans
Polymorphism Genetic
Receptors CCR5
Sjogren's Syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
topic Chemokine receptor CCR5
DNA
Cell migration
Cell surface
Colombia
DNA polymorphism
Frameshift mutation
Gene deletion
Gene frequency
Genetic association
Genotype
Human
Insulin dependent diabetes mellitus
Letter
Leukocyte
Priority journal
Sjoegren syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
Colombia
Diabetes Mellitus Type 1
Genetic Predisposition to Disease
Humans
Polymorphism Genetic
Receptors CCR5
Sjogren's Syndrome
CCR5 delta 32
Rs333
Sjögren's syndrome
Type 1 Diabetes
description Sjögren's syndrome (SS) and Type 1 Diabetes (T1D) are chronic, progressive autoimmune diseases that affect exocrine glands or ?-cells in the islets of Langerhans in the pancreas, respectively. Typical features of both diseases include production of antibodies against self-antigens and T and B cell infiltrates in organ-specific tissues [12] . Migration of pro-inflammatory memory T cells and monocytes into chronically inflamed tissues is driven by Th1-related chemokines and their receptors. This includes CCR5, a seven-transmembrane domain G protein-coupled receptor (GPCR) involved in intracellular signaling [3] . In Sjögren's syndrome, mRNA and receptor expression of CCR5 are significantly upregulated in inflammatory Th1 cells, parotid gland excretory ducts and conjunctival epithelium of SS-affected individuals indicating that it has a significant role in the progression and severity of pSS disease [45] . In Type 1 Diabetes, recruitment of activated CCR5-expressing T cells to the pancreas or kidney can promote renal disease and impairment of insulin production [6] .
publishDate 2013
dc.date.created.none.fl_str_mv 2013-08-01
dc.date.accessioned.none.fl_str_mv 2020-08-06T16:21:39Z
dc.date.available.none.fl_str_mv 2020-08-06T16:21:39Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.clim.2013.05.010
dc.identifier.issn.none.fl_str_mv ISSN: 1521-7035
Clinical Immunology
EISSN: 1521-6616
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/26418
url https://doi.org/10.1016/j.clim.2013.05.010
https://repository.urosario.edu.co/handle/10336/26418
identifier_str_mv ISSN: 1521-7035
Clinical Immunology
EISSN: 1521-6616
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 208
dc.relation.citationIssue.none.fl_str_mv No. 2
dc.relation.citationStartPage.none.fl_str_mv 206
dc.relation.citationTitle.none.fl_str_mv Clinical Immunology
dc.relation.citationVolume.none.fl_str_mv Vol. 148
dc.relation.ispartof.none.fl_str_mv Clinical Immunology, ISSN:1521-7035 ; EISSN:1521-6616, Vol.148, No.2 (August, 2013); pp.206-208
dc.relation.uri.none.fl_str_mv https://www.sciencedirect.com/science/article/abs/pii/S1521661613001307?via%3Dihub
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv Restringido (Acceso a grupos específicos)
rights_invalid_str_mv Restringido (Acceso a grupos específicos)
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167515883896832